Drug intelligence / Profile preview

Nuobaoneng

Development stage: Preclinical
Lead developer: Yinuo Pharmaceutical
Administration: Oral

Overview

Nuobaoneng is a special medical use formula, specifically a tumor nutritional formula, developed by Beijing Yinuo Pharmaceutical Co., Ltd. and Beijing Cancer Hospital. It is administered as a powder to provide nutritional support for malnourished tumor patients. As a nutritional supplement, its primary function is to address dietary deficiencies and support the overall health of patients undergoing cancer treatment.

Brand names: Nuobaoneng
Other names: 诺葆能

Beyond the preview

Go deeper on Nuobaoneng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuobaoneng.

Explore the full profile